#ESMOBreast24 The impact of #ClimateChange on a 🌍cancer clinical trials organisation 1:3 respondents impacted Existing sustainability engagement high Barriers to more assessed Tree of Solutions 👇 Tx to coauthors & @BIGagainstBC leadership

Excited to share our latest publication with Niamh Coleman, MD PhD : "Challenges and Opportunities in the Immunotherapy Era: Balancing Expectations with Hope in Small-Cell Lung Cancer." #CancerResearch #Immunotherapy #LungCancer journals.sagepub.com/doi/10.1177/17…

Oncologist: People with cancer are waiting too long for treatment in Ireland (via TheJournal.ie) jrnl.ie/6432861

Our dear Prof Seamus O’Reilly MD PhD chairing a session ESMO - Eur. Oncology 2024 on Climate Change: How to build a sustainable and environment friendly oncology care. Brilliant talks from all the speakers and thanks to highlight important factor which is not taken into account in daily practice.

Always a pleasure to present in 🇮🇪 observed by many who have contributed to my journey to date. Discussed NSCLC and made an argument for alternative drug doses, patient-involved decision making, CNS-specific strategies and improved drug access

Day 2 Gathering around Cancer conference highlighting the truly jaw dropping Irish graduates and the importance of access to Fellowships in Canada, U.S.A. and UK

Climate Therapy: Sustainability Solutions for Breast Cancer Care in the Anthropocene Era clinical-breast-cancer.com/article/S1526-… Sustainability 🌳 for ♻️ care Directory of ♻️ Clinical Toolkits🛠️ Insights for Dx 🧪& Tx 🩺 ✍️☘️🇺🇸🇨🇦🇮🇹🌷

Are You a Breast Cancer Survivor Wanting to Return to Work? Researchers from Trinity College Dublin have developed CanWork - a 6-week online education programme supporting women with breast cancer to return to work. 📅 Now enrolling participants for a national study.

🚨 The CAMBRIA-2 #BreastCancer trial, sponsored by AstraZeneca, is now open at St Vincent's University Hospital (SVUH), Cancer Trials Mater, and Beaumont RCSI Cancer Centre. Congrats to site PIs Michaela Higgins, Patrick Morris, Geraldine O'Sullivan Coyne & Prof Cathy Kelly, & NLI Seamus O’Reilly MD PhD Learn more: bit.ly/3C4eM4W

POLAR trial:🧊🖐️Hand cooling & compression significantly reduce risk of high-grade CIPN in #BreastCancer pts on taxanes! Cooling: 29% 🆚 50% (p=0.002) Compression: 24% 🆚 38% (p=0.008) 👉jamanetwork.com/journals/jamao… OncoAlert JAMA Oncology

Just published in Journal of Clinical Oncology the updated ASCO guidelines on fertility preservation in people with #cancer: a must read for all colleagues involved in cancer care to increase awareness on #oncofertility issues OncoAlert Ann Partridge MD, MPH Oncofertility Link: ascopubs.org/doi/10.1200/JC…

In a multivariable analysis, omitting ET was associated w/⬆️ risk of death HR 1.23; For ER 1%-5% HR 1.16; For ER 6%-10% HR 1.42 Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… OncoAlert

India has attacked, but Pakistan stands united—resolute, fearless, and firm in its defence. We stand with our nation and our forces. With Allah on our side, victory will be ours. Insh’Allah. #StandWithPakistan #PakistanZindabad #DefendPakistan

Grateful to the USA for its efforts toward a ceasefire between Pakistan & India - this is a victory for humanity and peace. Proud of the Armed Forces of Pakistan for their unwavering commitment to defending our homeland against an enemy driven by fanaticism

Well done to Karine and the team on this excellent poster, which highlights the financial and resource implications of genomic testing for both healthcare institutions and patients. #ESMOBreast25

Congratulations David O Reilly 🥳 very well deserved!

by Nick Rabbitts Doctor ‘traumatised’ after being assaulted and racially abused at Limerick hospital Condemnation for attack on Pakistani medic who was about to start shift in Emergency Department I hope Ireland is not heading towards racism. limerickleader.ie/#

📣 Randomized trial in 234 ppl w/ early #breastcancer on capecitabine for postneoadjuvant residual disease found methylcobalamin (Vit B12) 0.5 mg 3x per day was safe & cut risk of grade 2+ hand-foot syndrome in half vs placebo. NNT ~7. Link in 🧵. #OncTwitter #MedTwitter #bcsm

RCPI Annual Trainer Conference